The world could soon be armed with another tool to fight the coronavirus pandemic: a twice-daily pill that has been shown to reduce the risk of hospitalization and death among people infected with the coronavirus.
The drug, molnupiravir, offers another tool alongside vaccines for countries to manage the coronavirus pandemic. Here’s what you need to know about it:
Coronavirus maps: Cases and deaths in the U.S. | Cases and deaths worldwide
Vaccines: Tracker by state | Booster shots | For kids 5 to 11 | Guidance for vaccinated people | How long does immunity last? | County-level vaccine data
Do you think you’re experiencing long-haul covid symptoms? Share your experience with The Post.
What you need to know: Omicron variant | Masks FAQ | Delta variant | Other variants | Symptoms guide | Follow all of our coverage and sign up for our free newsletter
Impact of the pandemic: Supply chain | Education | Housing
Got a pandemic question? We answer one every day in our coronavirus newsletter